Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
White blood cell migration into the central nervous system is a tightly regulated, multi-step process essential for immune surveillance and response to injury or disease. This process is highly restricted under normal conditions due to specialized barriers but can be dramatically increased during neuroinflammatory or neurodegenerative diseases. Leukocytes enter the CNS via three main routes: the choroid plexus/blood-CSF barrier, the BBB/perivascular space, and the meningeal/subarachnoid pathways. Key steps include adhesion, chemotaxis, and transmigration, involving molecules like ICAM‐1, VCAM‐1, CLMP, CXCL12-CXCR4. While crucial for host defense, excessive or dysregulated migration contributes to the pathogenesis of various neurological disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on White Blood Cell Migration into the Central Nervous System.